Dosar de subiect
India's Affordable Weight-Loss Drugs May Impact Global Obesity
Primul articol: 18 mar. 2026, 02:30
|
Ultima actualizare: 18 mar. 2026, 02:30
|
1 sursa
|
1 articol
Mai multe surse. Mai putina manipulare.
Analiza editoriala
Bazat pe 1 sursa, 1 articol
The availability of inexpensive weight-loss medications from India offers a new approach to tackling the global obesity crisis. These drugs, produced at a fraction of the cost compared to those in Western markets, could make treatment accessible to a larger population, particularly in low- and middle-income countries where obesity rates are rising. This shift could lead to a re-evaluation of obesity treatment strategies, focusing on affordability and widespread availability.Articole despre acest subiect
Foto: BBC UK
India's cheap weight-loss drugs could reshape global obesity fight
With India’s semaglutide patent expiring on 20 March, about 50 branded generics are expected to enter the market.
Citeste pe BBC UK →